Position in SIGA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$75,242
-$10,420 QoQ
Shares Held
14,064
+0.3% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SIGA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $96,211,937 across 30 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
503,917 | $36,211,475 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
348,043 | $8,565,338 | |
| 3 | VTRS |
Viatris Inc
|
532,076 | $8,449,366 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
15,582 | $8,442,795 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
46,762 | $7,881,267 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
211,326 | $3,062,113 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
71,898 | $2,602,707 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
147,185 | $2,547,772 |
All Filings in SIGA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $75,242 | 14,064 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $85,662 | 14,020 | Shares | Sole | 2026-03-09 | |
| 2025-09-30 | $128,713 | 14,067 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $66,373 | 12,112 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $75,792 | 12,611 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $85,056 | 12,601 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||